These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 24266878)

  • 41. Qbrexza - A glycopyrronium cloth for axillary hyperhidrosis.
    Med Lett Drugs Ther; 2019 Jan; 61(1564):10-11. PubMed ID: 30856158
    [No Abstract]   [Full Text] [Related]  

  • 42. Topical glycopyrrolate reduces axillary hyperhidrosis.
    Baker DM
    J Eur Acad Dermatol Venereol; 2016 Dec; 30(12):2131-2136. PubMed ID: 27406319
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oxybutynin for hyperhidrosis.
    Lefrandt JD; Maurer JM
    Neth J Med; 2007 Oct; 65(9):356. PubMed ID: 17954957
    [No Abstract]   [Full Text] [Related]  

  • 44. [Topical glycopyrrolate in craniofacial hyperhidrosis].
    Callejas MA; Grimalt R
    Med Clin (Barc); 2008 Jun; 131(4):157. PubMed ID: 18601830
    [No Abstract]   [Full Text] [Related]  

  • 45. A randomized placebo-controlled trial of oxybutynin for the initial treatment of palmar and axillary hyperhidrosis.
    Wolosker N; de Campos JR; Kauffman P; Puech-Leão P
    J Vasc Surg; 2012 Jun; 55(6):1696-700. PubMed ID: 22341836
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Glycopyrrolate oral solution: for chronic, severe drooling in pediatric patients with neurologic conditions.
    Garnock-Jones KP
    Paediatr Drugs; 2012 Aug; 14(4):263-9. PubMed ID: 22646067
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of iontophoresis with glycopyrronium bromide for treatment of primary palmar hyperhidrosis.
    Chia HY; Tan AS; Chong WS; Tey HL
    J Eur Acad Dermatol Venereol; 2012 Sep; 26(9):1167-70. PubMed ID: 21812834
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oral medications.
    Glaser DA
    Dermatol Clin; 2014 Oct; 32(4):527-32. PubMed ID: 25152346
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oral Oxybutynin for Local and Multifocal Hyperhidrosis: A Multicenter Study.
    Toledo-Pastrana T; Márquez-Enríquez J; Millán-Cayetano JF
    Actas Dermosifiliogr; 2017; 108(6):597-599. PubMed ID: 28388990
    [No Abstract]   [Full Text] [Related]  

  • 50. Glycopyrronium Tosylate (Qbrexza) for Hyperhidrosis.
    Nwannunu CE; Limmer AL; Coleman K; Shah R; Patel RR; Mui UN; Tyring SK
    Skin Therapy Lett; 2019 Mar; 24(2):1-3. PubMed ID: 30970203
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Glycopyrrolate (Dartisla ODT) for peptic ulcer symptoms.
    Med Lett Drugs Ther; 2022 Feb; 64(1643):24. PubMed ID: 35134050
    [No Abstract]   [Full Text] [Related]  

  • 52. Pharmacometrics-guided drug development of antihyperhidrosis agents.
    Mehrotra S; Schmith VD; Dumitrescu TP; Gobburu J
    J Clin Pharmacol; 2015 Nov; 55(11):1256-67. PubMed ID: 25939678
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The use of oxybutynin for treating axillary hyperhidrosis.
    Wolosker N; de Campos JR; Kauffman P; Neves S; Munia MA; BiscegliJatene F; Puech-Leão P
    Ann Vasc Surg; 2011 Nov; 25(8):1057-62. PubMed ID: 22023940
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A randomised controlled trial of topical glycopyrrolate, the first specific treatment for diabetic gustatory sweating.
    Shaw JE; Abbott CA; Tindle K; Hollis S; Boulton AJ
    Diabetologia; 1997 Mar; 40(3):299-301. PubMed ID: 9084967
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Glycopyrronium (Qbrexza) Topical Wipes for Hyperhidrosis.
    Arnold MJ; O'Connor C
    Am Fam Physician; 2019 Sep; 100(6):372-373. PubMed ID: 31524358
    [No Abstract]   [Full Text] [Related]  

  • 56. [Glycopyrrolate treatment for drooling in an adult with cerebral palsy].
    Neverlien PO; Sørumshagen L; Eriksen T; Grinna T; Kvalshaugen H; Lind AB
    Tidsskr Nor Laegeforen; 2001 Jan; 121(2):187-8. PubMed ID: 11475197
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mydriasis secondary to use of glycopyrrolate cream.
    Radotra A; Baneke A; Paul B
    Br J Hosp Med (Lond); 2019 Dec; 80(12):736. PubMed ID: 31822169
    [No Abstract]   [Full Text] [Related]  

  • 58. Preliminary Experience with Transdermal Oxybutynin Patches for Hyperhidrosis.
    Bergón-Sendín M; Pulido-Pérez A; Sáez-Martín LC; Suárez-Fernández R
    Actas Dermosifiliogr; 2016 Dec; 107(10):845-850. PubMed ID: 27497508
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Residual limb hyperhidrosis successfully managed with topical glycopyrrolate.
    Kotitsas P; Tsiogka A; Agiasofitou E; Markantoni V; Gregoriou S; Platsidaki E; Rigopoulos D; Kontochristopoulos G
    Indian J Dermatol Venereol Leprol; 2022; 88(2):230-231. PubMed ID: 34877842
    [No Abstract]   [Full Text] [Related]  

  • 60. Pharmacology, toxicology and clinical safety of glycopyrrolate.
    Chabicovsky M; Winkler S; Soeberdt M; Kilic A; Masur C; Abels C
    Toxicol Appl Pharmacol; 2019 May; 370():154-169. PubMed ID: 30905688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.